Page last updated: 2024-08-24

ibandronic acid and Brittle Bone Disease

ibandronic acid has been researched along with Brittle Bone Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bayer, M; Kutílek, Š; Ondrušová, E; Plášilová, I; Skálová, S1
Han, LW; Hu, YY; Jiang, Y; Li, M; Liu, HJ; Meng, XW; Wang, O; Xia, WB; Xing, XP; Xu, L; Yu, W1

Trials

1 trial(s) available for ibandronic acid and Brittle Bone Disease

ArticleYear
Benefit of infusions with ibandronate treatment in children with osteogenesis imperfecta.
    Chinese medical journal, 2011, Volume: 124, Issue:19

    Topics: Bone Density Conservation Agents; Child; Child, Preschool; Diphosphonates; Female; Humans; Ibandronic Acid; Infant; Infant, Newborn; Infusions, Intravenous; Male; Osteogenesis Imperfecta; Prospective Studies

2011

Other Studies

1 other study(ies) available for ibandronic acid and Brittle Bone Disease

ArticleYear
Oral Ibandronate Therapy in Three Patients with Osteogenesis Imperfecta.
    Acta medica (Hradec Kralove), 2021, Volume: 64, Issue:3

    Topics: Administration, Oral; Adolescent; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Osteogenesis Imperfecta

2021